News

Clinical trials are using mRNA technology to develop personalized vaccines intended to prevent cancer from returning.

After learning she had breast cancer, Patricia Latham agreed to take part in a clinical trial to assess whether some women could avoid radiation.

Rare mutations could be a key to finding new treatments for lupus.

When Hurricane Helene disrupted IV fluid supply chain, MUSC anesthesia team got creative - and is now sharing valuable lessons learned.

A new clinical trial for women with recurrent ovarian cancer is an outgrowth of a long-term partnership between a researcher, a donor and physicians.

Could the way we preserve donor milk shape preemie gut health? A new MUSC study connects the dots between storage practices and GI outcomes.

MUSC study provides new insight that may lead to personalized repetitive transcranial magnetic stimulation, or rTMS, for smokers who want to quit.

Hollings researchers uncovered data showing that women who survive cervical cancer are at greater risk of anal cancer years down the road.

A clinical trial at Hollings is looking for answers to a problem that Dr. Avi Siva saw was affecting her triple negative breast cancer patients.

MUSC study finds a link between inflammation and poor neonatal and pregnancy outcomes.